Bayer Schering Pharma has announced that it will launch a 30-gauge needle for its multiple sclerosis treatment Betaferon in the US.According to the company, this needle will be the thinnest needle of any injectable disease-modifying therapy for people with multiple sclerosis (MS). The needle is said to be as thin as those commonly used for insulin and pediatric injections.
No Pingbacks for this post yet...
The healthcare industry is an ever-changing, ever-adapting environment. MET can help you ensure you are kept up to date by providing you with the latest industry news.
| Mon | Tue | Wed | Thu | Fri | Sat | Sun |
|---|---|---|---|---|---|---|
| << < | > >> | |||||
| 1 | 2 | 3 | 4 | 5 | 6 | 7 |
| 8 | 9 | 10 | 11 | 12 | 13 | 14 |
| 15 | 16 | 17 | 18 | 19 | 20 | 21 |
| 22 | 23 | 24 | 25 | 26 | 27 | 28 |
| 29 | 30 | 31 | ||||